Literature DB >> 20524959

Compound K, a metabolite of ginsenosides, facilitates spontaneous GABA release onto CA3 pyramidal neurons.

Man-Yeol Bae1, Jin-Hwa Cho, In-Sun Choi, Hye-Mi Park, Maan-Gee Lee, Dong-Hyun Kim, Il-Sung Jang.   

Abstract

Ginsenoside Rb1, a major ingredient of ginseng saponins, can affect various brain functions, including learning and memory. When ingested orally, ginsenoside Rb1 is not found in plasma as well as urine, but its metabolite compound K (ComK) reaches the systemic circulation in animals and human. Nevertheless, the pharmacological actions of ComK are still poorly known. In the present study, we investigated the effect of ComK on GABAergic spontaneous miniature inhibitory post-synaptic currents (mIPSCs) in acutely isolated rat hippocampal CA3 pyramidal neurons using a conventional whole-cell patch-clamp technique. While ComK significantly increased mIPSC frequency in a concentration-dependent manner, it had no effect on the current amplitude, suggesting that ComK acts pre-synaptically to increase the probability of spontaneous GABA release. ComK still increased mIPSC frequency even in a Ca(2+) -free external solution, suggesting that the ComK-induced increase spontaneous GABA release is not related to Ca(2+) influx from the extracellular space. However, the ComK-induced increase mIPSC frequency was significantly decreased after the blockade of either sarcoplasmic/endoplasmic reticulum Ca(2+) -ATPase or Ca(2+) release channels. These results strongly suggest that ComK enhances spontaneous GABA release by increasing intraterminal Ca(2+) concentration via Ca(2+) release from pre-synaptic Ca(2+) stores. The ComK-induced modulation of inhibitory transmission onto CA3 pyramidal neurons could have a broad impact on the excitability of CA3 pyramidal neurons and affect the physiological functions mediated by the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524959     DOI: 10.1111/j.1471-4159.2010.06833.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Antidepressant Effects of the Ginsenoside Metabolite Compound K, Assessed by Behavioral Despair Test and Chronic Unpredictable Mild Stress Model.

Authors:  Wu Song; Yan Guo; Shuang Jiang; Lin Wei; Zhi Liu; Xiaoyan Wang; Ying Su
Journal:  Neurochem Res       Date:  2018-05-22       Impact factor: 3.996

2.  Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway.

Authors:  Kuo-Feng Hua; A-Ching Chao; Ting-Yu Lin; Wan-Tze Chen; Yu-Chieh Lee; Wan-Han Hsu; Sheau-Long Lee; Hsin-Min Wang; Ding-I Yang; Tz-Chuen Ju
Journal:  J Ginseng Res       Date:  2021-11-11       Impact factor: 5.735

3.  Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice.

Authors:  Yan Liu; Xiaodan Zong; Jie Huang; Yanfei Guan; Yuanquan Li; Ting Du; Keyin Liu; Xinpan Kang; Chunyan Dou; Xiangdong Sun; Renhua Wu; Lei Wen; Yunlong Zhang
Journal:  Aging (Albany NY)       Date:  2019-07-17       Impact factor: 5.682

4.  Constitutive and Stress-Induced Psychomotor Cortical Responses to Compound K Supplementation.

Authors:  Shawn D Flanagan; Felix Proessl; Courtenay Dunn-Lewis; Maria C Canino; Adam J Sterczala; Chris Connaboy; William H DuPont; Lydia K Caldwell; William J Kraemer
Journal:  Front Neurosci       Date:  2020-04-08       Impact factor: 4.677

Review 5.  A narrative review of the pharmacology of ginsenoside compound K.

Authors:  Tao Liu; Lu Zhu; Li Wang
Journal:  Ann Transl Med       Date:  2022-02

6.  A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.

Authors:  Hee Jin Kim; Pitna Kim; Chan Young Shin
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

7.  The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway.

Authors:  Xiangchang Zeng; Kai Hu; Lulu Chen; Luping Zhou; Wei Luo; Chaopeng Li; Wenjing Zong; Siyu Chen; Qing Gao; Guirong Zeng; Dejian Jiang; Xiaohui Li; Honghao Zhou; Dong-Sheng Ouyang
Journal:  Front Pharmacol       Date:  2018-09-11       Impact factor: 5.810

8.  GS-KG9 ameliorates diabetic neuropathic pain induced by streptozotocin in rats.

Authors:  Jee Youn Lee; Hae Young Choi; Chan Sol Park; Mi Kyung Pyo; Tae Young Yune; Go Woon Kim; Sung Hyun Chung
Journal:  J Ginseng Res       Date:  2017-08-16       Impact factor: 6.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.